top of page

Process
Technology
Partnerships
Case Studies & Pipeline
News
Contact
About
More

Use tab to navigate through the menu items.

Dark background with hint of blue abstract data.jpg

News

Subscribe to Newsletter

Qubigen Signs Data Access Agreement with Flinders University

Qubigen Signs Data Access Agreement with Flinders University

Qubigen Signs Data Access Agreement with Flinders University

Qubigen is pleased to announce the signing of a Data Access Master Agreement with Flinders University , establishing a framework for...

Sep 4, 20252 min read

Qubigen Co-Founder Dr Jun Zeng Elected Fellow of the Royal Australian Chemical Institute (FRACI)

Qubigen Co-Founder Dr Jun Zeng Elected Fellow of the Royal Australian Chemical Institute (FRACI)

Qubigen Co-Founder Dr Jun Zeng Elected Fellow of the Royal Australian Chemical Institute (FRACI)

Qubigen is proud to announce that Dr Jun Zeng, Co-Founder and Chief Information Officer, has been elected as a Fellow of the Royal...

Sep 4, 20251 min read

Unlocking Secure, Targeted Drug Design with Federated AI and Node-Level Control

Unlocking Secure, Targeted Drug Design with Federated AI and Node-Level Control

Unlocking Secure, Targeted Drug Design with Federated AI and Node-Level Control

At Qubigen, we believe that world-class drug design demands more than just high-quality datasets or cutting-edge algorithms, it also...

Aug 7, 20253 min read

enquiries@qubigen.com

Bio21 Institute

30 Flemington Road

Parkville VIC 3052

Australia

Accelerate drug design
without exposing secrets

Connect with Us

© 2025 Qubigen. All rights reserved.

bottom of page